Slipped Capital Femoral Epiphysis News and Research

RSS

A slipped capital femoral epiphysis (SCFE) is a condition in which the head of the femur separates from the adjacent growth plate or epiphysis at the upper end of the femur.

Obesity in early childhood linked to higher rates of musculoskeletal consultations

The incidence of musculoskeletal consultations in children with obesity in a primary care setting.

13 Mar 2024

Pathophysiology, comorbidities, and interventions related to childhood obesity

Researchers discuss the psychological and physiological impacts of obesity on children.

6 Apr 2023

Study suggests rising childhood obesity rates as cause for serious hip disease in adolescents

New research suggests that rising childhood obesity rates are causing more adolescents to develop a debilitating hip disease requiring urgent surgery.

22 Oct 2018

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved ZOMACTON for injection in four additional pediatric indications

20 Jul 2018

3D-printed models help shorten surgery time for common hip disorder in children

A team of engineers and pediatric orthopedic surgeons are using 3D printing to help train surgeons and shorten surgeries for the most common hip disorder found in children ages 9 to 16.

2 Aug 2017

New study shows strong link between childhood obesity and hip diseases

New research from the University, published in the Archives of Disease in Childhood journal, shows a strong link between childhood obesity and hip diseases in childhood.

7 Jul 2017

Early treatment of chronic hip pain in young athletes may have long term impact on health

Treating young athletes with chronic hip pain may be the key to slowing or halting the progression of degenerative hip disease.

3 Sep 2011

FDA approves Norditropin for short stature in children with Noonan syndrome

Novo Nordisk has announced that Norditropin (somatropin[rDNA origin] injection) received U.S. Food and Drug Administration (FDA) approval for the treatment of short stature in children with Noonan syndrome.

3 Jun 2007